Recently, Lcn2 has emerged as an important component of pathophysiology of several disorders, including Alzheimer’s disease (AD), Parkinson’s disease, multiple sclerosis and depression [47,48,49,50]. The gene discussed is LCN2; the disease is early-onset autosomal dominant Alzheimer disease.